Elevated Cardiac Troponin I following Asymptomatic Intradialytic Hypotension: A Pilot Study with a 2-Year Follow-Up

Toktam Alirezaei1, Mir Jafar Jebreil Moosavi1, Rana Irilouzadian2

  • 1Clinical Research Development Unit of Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Insights

Asymptomatic intradialytic hypotension (IDH) during hemodialysis (HD) is linked to increased cardiac troponin I (cTnI) levels in end-stage renal disease (ESRD) patients. Monitoring blood pressure during HD is crucial for predicting cardiac events.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Medicine

Background:

  • Intradialytic hypotension (IDH) is a common complication in hemodialysis (HD) for end-stage renal disease (ESRD) patients.
  • The impact of asymptomatic IDH on cardiac troponin I (cTnI) levels remains unclear.

Purpose of the Study:

  • To investigate the association between asymptomatic IDH and elevated cTnI levels.
  • To evaluate the long-term cardiovascular outcomes in ESRD patients undergoing HD.

Main Methods:

  • 70 asymptomatic ESRD patients with negative predialysis cTnI were monitored during HD sessions.
  • Hemodynamic changes and symptoms were recorded.
  • Patients were followed for two years for acute coronary syndrome (ACS) and cardiac death.

Main Results:

  • Asymptomatic IDH was identified in 38.6% of patients based on 2007 guidelines.
  • A significant correlation was found between asymptomatic IDH and elevated postdialysis cTnI levels (r=0.492, p<0.05).
  • Patients with elevated cTnI experienced more ACS and cardiac death during follow-up.

Conclusions:

  • Asymptomatic IDH during HD significantly affects cTnI levels in ESRD patients.
  • Elevated cTnI, influenced by asymptomatic IDH, predicts adverse cardiovascular outcomes.
  • Monitoring blood pressure during HD is critical for managing cardiovascular risk in ESRD patients.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
296
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
67
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
140
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
46
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
55